<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND/AIMS: Cadherins are cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules that are thought to play a vital role in cell-cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e>; loss or down-regulation of their expression has been implicated in <z:hpo ids='HP_0002664'>neoplasia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Barrett's esophageal columnar <z:mpath ids='MPATH_160'>metaplasia</z:mpath> (BE) is a <z:e sem="disease" ids="C0850639" disease_type="Neoplastic Process" abbrv="">premalignant lesion</z:e> for esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> with clinical symptoms similar to those of <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> and <z:hpo ids='HP_0100633'>esophagitis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we investigated the potential relationship between E-cadherin expression and <z:mp ids='MP_0001845'>inflammation</z:mp>, <z:mpath ids='MPATH_160'>metaplasia</z:mpath>, and <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> in <z:hpo ids='HP_0100633'>esophagitis</z:hpo>, BE, and esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Endoscopically obtained mucosal biopsy specimens of <z:hpo ids='HP_0100633'>esophagitis</z:hpo> (n = 6), BE with or without <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (n = 16), and esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (n = 6) were analyzed for the expression of E-cadherin by both Western analysis and immunoperoxidase staining </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Densitometric analysis of Western blots revealed the expression of E-cadherin to be significantly lower in patients with BE compared with <z:mpath ids='MPATH_458'>normal</z:mpath> esophageal epithelium, regardless of the presence or absence of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (p &lt; 0.03) </plain></SENT>
<SENT sid="5" pm="."><plain>No significant differences were noticed between the <z:mpath ids='MPATH_458'>normal</z:mpath> esophagus and the <z:hpo ids='HP_0100633'>esophagitis</z:hpo> groups </plain></SENT>
<SENT sid="6" pm="."><plain>In the <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> group, one patient showed complete loss of E-cadherin expression, and the other five patients showed significantly reduced expression that was even lower than that in BE (p &lt; 0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>Immunoperoxidase staining matched the Western analysis results </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: We conclude that loss of or reduced E-cadherin expression may play a role in the progression of BE to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
</text></document>